From February 6, 2024 to March 31, 2024, the company has repurchased 1,796,900 shares, representing 0.29% for CNY 22.86 million. With this, the company has completed the repurchase of 1,796,900 shares, representing 0.29% for CNY 22.86 million under the buyback announced on February 6, 2024.
Maccura Biotechnology Co.Ltd
Equities
300463
CNE1000020H3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.35 CNY | -0.60% | -2.98% | -11.41% |
25/04 | Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2023 | CI |
24/04 | Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.41% | 112.01Cr | |
-1.52% | 836.62Cr | |
+10.68% | 595.76Cr | |
+26.94% | 545.49Cr | |
-5.09% | 434.31Cr | |
-52.54% | 317.95Cr | |
+14.18% | 274.54Cr | |
+32.50% | 229.53Cr | |
-6.47% | 227.88Cr | |
-1.69% | 192.09Cr |
- Stock Market
- Equities
- 300463 Stock
- News Maccura Biotechnology Co.Ltd
- Tranche Update on Maccura Biotechnology Co.Ltd's Equity Buyback Plan announced on February 6, 2024.